{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 377719, "items": [{"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T20:38:22Z", "timestamp": 1574282302981}, "reference-count": 34, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 1, 1]], "date-time": "2009-01-01T00:00:00Z", "timestamp": 1230768000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Seminars in Hematology"], "published-print": {"date-parts": [[2009, 1]]}, "DOI": "10.1053/j.seminhematol.2008.12.007", "type": "journal-article", "created": {"date-parts": [[2009, 2, 25]], "date-time": "2009-02-25T09:42:52Z", "timestamp": 1235554972000}, "page": "S26-S32", "source": "Crossref", "is-referenced-by-count": 53, "title": ["Management of Chemotherapy-Induced Thrombocytopenia: Current Status of Thrombopoietic Agents"], "prefix": "10.1053", "volume": "46", "author": [{"given": "Saroj", "family": "Vadhan-Raj", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Seminars in Hematology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0037196308002060?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0037196308002060?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T07:49:45Z", "timestamp": 1558165785000}, "score": 80.51154, "issued": {"date-parts": [[2009, 1]]}, "references-count": 34, "alternative-id": ["S0037196308002060"], "URL": "http://dx.doi.org/10.1053/j.seminhematol.2008.12.007", "ISSN": ["0037-1963"], "issn-type": [{"value": "0037-1963", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:10:36Z", "timestamp": 1574115036280}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2, Suppl 4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2000, 4, 1]], "date-time": "2000-04-01T00:00:00Z", "timestamp": 954547200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2000, 4]]}, "DOI": "10.1053/shem.2000.7391", "type": "journal-article", "created": {"date-parts": [[2002, 8, 25]], "date-time": "2002-08-25T03:46:10Z", "timestamp": 1030247170000}, "page": "28-34", "source": "Crossref", "is-referenced-by-count": 16, "title": ["Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia"], "prefix": "10.1053", "volume": "37", "author": [{"given": "Saroj", "family": "Vadhan-Raj", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Seminars in Hematology"], "deposited": {"date-parts": [[2019, 4, 12]], "date-time": "2019-04-12T01:50:30Z", "timestamp": 1555033830000}, "score": 44.996727, "issued": {"date-parts": [[2000, 4]]}, "references-count": 0, "journal-issue": {"issue": "2, Suppl 4"}, "alternative-id": ["10.1053/shem.2000.7391"], "URL": "http://dx.doi.org/10.1053/shem.2000.7391", "ISSN": ["0037-1963"], "issn-type": [{"value": "0037-1963", "type": "print"}], "article-number": "ashem0370028"}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T07:24:22Z", "timestamp": 1575185062422}, "reference-count": 23, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2000, 4, 1]], "date-time": "2000-04-01T00:00:00Z", "timestamp": 954547200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Seminars in Hematology"], "published-print": {"date-parts": [[2000, 4]]}, "DOI": "10.1016/s0037-1963(00)90050-7", "type": "journal-article", "created": {"date-parts": [[2005, 11, 3]], "date-time": "2005-11-03T12:48:22Z", "timestamp": 1131022102000}, "page": "28-34", "source": "Crossref", "is-referenced-by-count": 22, "title": ["Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia"], "prefix": "10.1016", "volume": "37", "author": [{"given": "Saroj", "family": "Vadhan-Raj", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Seminars in Hematology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0037196300900507?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0037196300900507?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 4]], "date-time": "2019-04-04T02:46:57Z", "timestamp": 1554346017000}, "score": 44.996727, "issued": {"date-parts": [[2000, 4]]}, "references-count": 23, "alternative-id": ["S0037196300900507"], "URL": "http://dx.doi.org/10.1016/s0037-1963(00)90050-7", "ISSN": ["0037-1963"], "issn-type": [{"value": "0037-1963", "type": "print"}], "subject": ["Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T15:58:21Z", "timestamp": 1574438301897}, "reference-count": 52, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 7, 1]], "date-time": "2010-07-01T00:00:00Z", "timestamp": 1277942400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Seminars in Hematology"], "published-print": {"date-parts": [[2010, 7]]}, "DOI": "10.1053/j.seminhematol.2010.03.004", "type": "journal-article", "created": {"date-parts": [[2010, 6, 21]], "date-time": "2010-06-21T00:46:42Z", "timestamp": 1277081202000}, "page": "249-257", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Clinical Findings With the First Generation of Thrombopoietic Agents"], "prefix": "10.1053", "volume": "47", "author": [{"given": "Saroj", "family": "Vadhan-Raj", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Seminars in Hematology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0037196310000454?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0037196310000454?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 10]], "date-time": "2018-12-10T07:56:32Z", "timestamp": 1544428592000}, "score": 44.913773, "issued": {"date-parts": [[2010, 7]]}, "references-count": 52, "journal-issue": {"published-print": {"date-parts": [[2010, 7]]}, "issue": "3"}, "alternative-id": ["S0037196310000454"], "URL": "http://dx.doi.org/10.1053/j.seminhematol.2010.03.004", "ISSN": ["0037-1963"], "issn-type": [{"value": "0037-1963", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T10:03:26Z", "timestamp": 1574503406816}, "edition-number": "First", "reference-count": 39, "publisher": "Informa Healthcare", "isbn-type": [{"value": "142005290X", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2008, 4]]}, "DOI": "10.3109/9781420052909.008", "type": "book-chapter", "created": {"date-parts": [[2011, 4, 3]], "date-time": "2011-04-03T01:04:33Z", "timestamp": 1301792673000}, "page": "1-18", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Thrombocytopenia and Thrombopoetic Growth Factors"], "prefix": "10.3109", "author": [{"given": "Jennifer", "family": "Wright", "sequence": "first", "affiliation": []}, {"given": "Saroj", "family": "Vadhan-Raj", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2010, 7, 28]]}, "reference": [{"key": "ch8-B1", "author": "Deutsch VR", "volume": "134", "first-page": "453", "year": "2006", "journal-title": "BJH", "DOI": "10.1111/j.1365-2141.2006.06215.x", "doi-asserted-by": "crossref"}, {"issue": "3", "key": "ch8-B2", "first-page": "261", "volume": "35", "author": "Vadhan-Raj S", "year": "1998", "journal-title": "Semin Hematol"}, {"issue": "2", "key": "ch8-B3", "doi-asserted-by": "crossref", "first-page": "28", "DOI": "10.1053/shem.2000.7391", "volume": "37", "author": "Vadhan-Raj S", "year": "2000", "journal-title": "Semin Hematol"}, {"key": "ch8-B4", "author": "Douglas VK", "volume": "117", "first-page": "844", "year": "2002", "journal-title": "Am J Clin Pathol", "DOI": "10.1309/09NP-3DFG-BLM9-E5LE", "doi-asserted-by": "crossref"}, {"issue": "10", "key": "ch8-B5", "doi-asserted-by": "crossref", "first-page": "999", "DOI": "10.1007/s00520-006-0079-9", "volume": "14", "author": "Hauser CA", "year": "2006", "journal-title": "Support Care Cancer"}, {"issue": "7", "key": "ch8-B6", "first-page": "649", "volume": "4", "author": "Smith RE", "year": "2006", "journal-title": "JNCCN"}, {"key": "ch8-B7", "DOI": "10.1002/cncr.11195", "doi-asserted-by": "publisher"}, {"key": "ch8-B8", "author": "Schiffer CA", "volume": "19", "first-page": "1519", "year": "2001", "journal-title": "JCO", "DOI": "10.1200/JCO.2001.19.5.1519", "doi-asserted-by": "crossref"}, {"issue": "4", "key": "ch8-B9", "doi-asserted-by": "crossref", "first-page": "707", "DOI": "10.1200/JCO.1994.12.4.707", "volume": "12", "author": "Vadhan-Raj S", "year": "1994", "journal-title": "JCO"}, {"issue": "3", "key": "ch8-B10", "first-page": "253", "volume": "35", "author": "Maslak P", "year": "1998", "journal-title": "Semin Hematol"}, {"issue": "11", "key": "ch8-B11", "doi-asserted-by": "crossref", "first-page": "2063", "DOI": "10.1200/JCO.1993.11.11.2063", "volume": "11", "author": "D'Hondt V", "year": "1993", "journal-title": "JCO"}, {"key": "ch8-B12", "author": "Lindemann A", "volume": "9", "first-page": "2120", "year": "1991", "journal-title": "JCO", "DOI": "10.1200/JCO.1991.9.12.2120", "doi-asserted-by": "crossref"}, {"issue": "4", "key": "ch8-B13", "doi-asserted-by": "crossref", "first-page": "715", "DOI": "10.1200/JCO.1994.12.4.715", "volume": "12", "author": "Vadhan-Raj S", "year": "1994", "journal-title": "JOC"}, {"issue": "9", "key": "ch8-B14", "first-page": "3607", "volume": "87", "author": "Tepler I", "year": "1996", "journal-title": "Blood"}, {"key": "ch8-B15", "DOI": "10.1056/NEJM199702063360603", "doi-asserted-by": "publisher"}, {"key": "ch8-B16", "author": "Basser RL", "volume": "89", "first-page": "3118", "year": "1997", "journal-title": "Blood"}, {"key": "ch8-B17", "author": "Schuster MW", "volume": "30", "first-page": "1044", "year": "2002", "journal-title": "Exp Hematol", "DOI": "10.1016/S0301-472X(02)00878-0", "doi-asserted-by": "crossref"}, {"key": "ch8-B18", "author": "Archimbaud E", "volume": "94", "first-page": "3694", "year": "1999", "journal-title": "Blood"}, {"key": "ch8-B19", "author": "Schiffer CA", "volume": "95", "first-page": "2530", "year": "2000", "journal-title": "Blood"}, {"key": "ch8-B20", "author": "Vadhan-Raj S", "volume": "126", "first-page": "673", "year": "1997", "journal-title": "Ann Int Med", "DOI": "10.7326/0003-4819-126-9-199705010-00001", "doi-asserted-by": "crossref"}, {"issue": "16", "key": "ch8-B21", "doi-asserted-by": "crossref", "first-page": "3158", "DOI": "10.1200/JCO.2003.08.003", "volume": "21", "author": "Vadhan-Raj S", "year": "2003", "journal-title": "JCO"}, {"key": "ch8-B22", "author": "Vadhan-Raj S", "volume": "132", "first-page": "364", "year": "2000", "journal-title": "Ann Intern Med", "DOI": "10.7326/0003-4819-132-5-200003070-00005", "doi-asserted-by": "crossref"}, {"issue": "4", "key": "ch8-B23", "doi-asserted-by": "crossref", "first-page": "715", "DOI": "10.1200/JCO.1994.12.4.715", "volume": "12", "author": "Vadhan-Raj S", "year": "1994", "journal-title": "JCO"}, {"issue": "2", "key": "ch8-B24", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1053/shem.2000.7388", "volume": "37", "author": "Demetri GD", "year": "2000", "journal-title": "Semin Hematol"}, {"issue": "2", "key": "ch8-B25", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1053/shem.2000.7387", "volume": "37", "author": "Begley CG", "year": "2000", "journal-title": "Semin Hematol"}, {"key": "ch8-B26", "DOI": "10.1002/ajh.1181", "doi-asserted-by": "publisher"}, {"key": "ch8-B27", "DOI": "10.1182/blood.V100.2.728", "doi-asserted-by": "publisher"}, {"key": "ch8-B28", "DOI": "10.1182/blood.V98.12.3241", "doi-asserted-by": "publisher"}, {"key": "ch8-B29", "DOI": "10.1182/blood.V100.10.3457", "doi-asserted-by": "publisher"}, {"key": "ch8-B30", "author": "Vadhan-Raj S", "volume": "359", "first-page": "2145", "year": "2002", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(02)09090-6", "doi-asserted-by": "crossref"}, {"key": "ch8-B31", "author": "Fibbe WE", "volume": "86", "first-page": "3308", "year": "1995", "journal-title": "Blood"}, {"issue": "9", "key": "ch8-B32", "first-page": "2798", "volume": "93", "author": "Somlo G", "year": "1999", "journal-title": "Blood"}, {"key": "ch8-B33", "author": "Bussel J", "volume": "108", "year": "2006", "journal-title": "Blood"}, {"key": "ch8-B34", "author": "Kutler DJ", "volume": "108", "year": "2006", "journal-title": "Blood"}, {"key": "ch8-B35", "author": "Kutler DJ", "volume": "109", "first-page": "4607", "year": "2007", "journal-title": "Blood", "DOI": "10.1182/blood-2006-10-019315", "doi-asserted-by": "crossref"}, {"key": "ch8-B36", "DOI": "10.1056/NEJMoa054626", "doi-asserted-by": "publisher"}, {"key": "ch8-B37", "author": "Fielder PJ", "volume": "87", "first-page": "2154", "year": "1996", "journal-title": "Blood"}, {"key": "ch8-B38", "DOI": "10.1002/cncr.11195", "doi-asserted-by": "publisher"}, {"key": "ch8-B39", "author": "Basser RL", "volume": "18", "first-page": "2852", "year": "2000", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.2000.18.15.2852", "doi-asserted-by": "crossref"}], "container-title": ["Cancer Supportive Care: Advances in Therapeutic Strategies", "Translational Medicine"], "deposited": {"date-parts": [[2019, 6, 9]], "date-time": "2019-06-09T16:56:57Z", "timestamp": 1560099417000}, "score": 31.760258, "issued": {"date-parts": [[2008, 4]]}, "ISBN": ["142005290X"], "references-count": 39, "alternative-id": ["10.3109/9781420052909.008", "10.3109/tms", "10.3109/9781420052909"], "URL": "http://dx.doi.org/10.3109/9781420052909.008", "relation": {"cites": []}, "ISSN": ["2158-0790", "2158-0804"], "issn-type": [{"value": "2158-0790", "type": "print"}, {"value": "2158-0804", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T14:11:51Z", "timestamp": 1575209511567}, "reference-count": 0, "publisher": "American College of Physicians", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Ann Intern Med"], "published-print": {"date-parts": [[2010, 9, 21]]}, "DOI": "10.7326/0003-4819-153-6-201009210-00003", "type": "journal-article", "created": {"date-parts": [[2013, 4, 12]], "date-time": "2013-04-12T19:08:50Z", "timestamp": 1365793730000}, "page": "358", "source": "Crossref", "is-referenced-by-count": 33, "title": ["Single-Dose Palifermin Prevents Severe Oral Mucositis During Multicycle Chemotherapy in Patients With Cancer"], "prefix": "10.7326", "volume": "153", "author": [{"given": "Saroj", "family": "Vadhan-Raj", "sequence": "first", "affiliation": []}], "member": "4285", "container-title": ["Annals of Internal Medicine"], "language": "en", "deposited": {"date-parts": [[2013, 10, 7]], "date-time": "2013-10-07T10:31:04Z", "timestamp": 1381141864000}, "score": 30.056614, "subtitle": ["A Randomized Trial"], "issued": {"date-parts": [[2010, 9, 21]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2010, 9, 21]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.7326/0003-4819-153-6-201009210-00003", "ISSN": ["0003-4819"], "issn-type": [{"value": "0003-4819", "type": "print"}], "subject": ["Internal Medicine", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:58:32Z", "timestamp": 1576799912642}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "15_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2008, 5, 20]]}, "DOI": "10.1200/jco.2008.26.15_suppl.20519", "type": "journal-article", "created": {"date-parts": [[2017, 2, 24]], "date-time": "2017-02-24T07:33:44Z", "timestamp": 1487921624000}, "page": "20519-20519", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Incidence and significant predicting factors for chemotherapy-induced severe thrombocytopenia in lymphoma patients"], "prefix": "10.1200", "volume": "26", "author": [{"given": "X.", "family": "Zhou", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Huen", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Teegala", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Ji", "sequence": "additional", "affiliation": []}, {"given": "L. E.", "family": "Fayad", "sequence": "additional", "affiliation": []}, {"given": "F. B.", "family": "Hagemeister", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Vadhan-Raj", "sequence": "additional", "affiliation": []}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2008.26.15_suppl.20519", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:21:57Z", "timestamp": 1574889717000}, "score": 27.956991, "issued": {"date-parts": [[2008, 5, 20]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2008, 5, 20]]}, "issue": "15_suppl"}, "alternative-id": ["10.1200/jco.2008.26.15_suppl.20519"], "URL": "http://dx.doi.org/10.1200/jco.2008.26.15_suppl.20519", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T03:52:15Z", "timestamp": 1574826735762}, "publisher-location": "Cambridge", "reference-count": 0, "publisher": "Cambridge University Press", "isbn-type": [{"value": "9781316443378", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1017/cbo9781316443378.030", "type": "book-chapter", "created": {"date-parts": [[2016, 8, 5]], "date-time": "2016-08-05T05:05:40Z", "timestamp": 1470373540000}, "page": "71-73", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Heparin-induced thrombocytopenia"], "prefix": "10.1017", "author": [{"given": "Raj", "family": "Nichani", "sequence": "first", "affiliation": []}, {"given": "Brendan", "family": "McGrath", "sequence": "additional", "affiliation": []}], "member": "56", "container-title": ["OSCEs for the Final FFICM"], "deposited": {"date-parts": [[2018, 4, 12]], "date-time": "2018-04-12T19:17:27Z", "timestamp": 1523560647000}, "score": 26.09814, "issued": {"date-parts": [[null]]}, "ISBN": ["9781316443378"], "references-count": 0, "URL": "http://dx.doi.org/10.1017/cbo9781316443378.030"}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T10:09:55Z", "timestamp": 1574158195145}, "reference-count": 42, "publisher": "Wiley", "issue": "6", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4565, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer"], "published-print": {"date-parts": [[2003, 3, 15]]}, "DOI": "10.1002/cncr.11195", "type": "journal-article", "created": {"date-parts": [[2003, 3, 18]], "date-time": "2003-03-18T22:44:31Z", "timestamp": 1048027471000}, "page": "1541-1550", "source": "Crossref", "is-referenced-by-count": 41, "title": ["Cost of chemotherapy-induced thrombocytopenia among patients with lymphoma or solid tumors"], "prefix": "10.1002", "volume": "97", "author": [{"given": "Linda S.", "family": "Elting", "sequence": "first", "affiliation": []}, {"given": "Scott B.", "family": "Cantor", "sequence": "additional", "affiliation": []}, {"given": "Charles G.", "family": "Martin", "sequence": "additional", "affiliation": []}, {"given": "Lois", "family": "Hamblin", "sequence": "additional", "affiliation": []}, {"given": "Danna", "family": "Kurtin", "sequence": "additional", "affiliation": []}, {"given": "Edgardo", "family": "Rivera", "sequence": "additional", "affiliation": []}, {"given": "Saroj", "family": "Vadhan-Raj", "sequence": "additional", "affiliation": []}, {"given": "Robert S.", "family": "Benjamin", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2003, 3, 3]]}, "reference": [{"key": "BIB1", "author": "Gaydos", "volume": "266", "first-page": "905", "year": "1962", "journal-title": "N Engl J Med.", "DOI": "10.1056/NEJM196205032661802", "doi-asserted-by": "crossref"}, {"key": "BIB2", "author": "Belt", "volume": "239", "first-page": "2571", "year": "1978", "journal-title": "JAMA.", "DOI": "10.1001/jama.239.24.2571", "doi-asserted-by": "crossref"}, {"key": "BIB3", "author": "Dutcher", "volume": "53", "first-page": "557", "year": "1984", "journal-title": "Cancer.", "DOI": "10.1002/1097-0142(19840201)53:3<557::AID-CNCR2820530331>3.0.CO;2-7", "doi-asserted-by": "crossref"}, {"key": "BIB4", "author": "Goldberg", "volume": "12", "first-page": "2317", "year": "1994", "journal-title": "J Clin Oncol.", "DOI": "10.1200/JCO.1994.12.11.2317", "doi-asserted-by": "crossref"}, {"key": "BIB5", "author": "Fanning", "volume": "59", "first-page": "191", "year": "1995", "journal-title": "Gynecol Oncol.", "DOI": "10.1006/gyno.1995.0006", "doi-asserted-by": "crossref"}, {"key": "BIB6", "author": "Beutler", "volume": "139", "first-page": "221", "year": "1979", "journal-title": "Arch Intern Med.", "DOI": "10.1001/archinte.1979.03630390073026", "doi-asserted-by": "crossref"}, {"key": "BIB7", "author": "Baer", "volume": "32", "first-page": "377", "year": "1992", "journal-title": "Transfusion.", "DOI": "10.1046/j.1537-2995.1992.32492263454.x", "doi-asserted-by": "crossref"}, {"key": "BIB8", "author": "Schiffer", "volume": "32", "first-page": "295", "year": "1992", "journal-title": "Transfusion.", "DOI": "10.1046/j.1537-2995.1992.32492263438.x", "doi-asserted-by": "crossref"}, {"key": "BIB9", "author": "Beutler", "volume": "81", "first-page": "1411", "year": "1993", "journal-title": "Blood."}, {"key": "BIB10", "author": "Pisciotto", "volume": "35", "first-page": "498", "year": "1995", "journal-title": "Transfusion.", "DOI": "10.1046/j.1537-2995.1995.35695288769.x", "doi-asserted-by": "crossref"}, {"key": "BIB11", "author": "Norfolk", "volume": "101", "first-page": "609", "year": "1998", "journal-title": "B J Haemat.", "DOI": "10.1046/j.1365-2141.1998.00773.x", "doi-asserted-by": "crossref"}, {"key": "BIB12", "author": "Heckman", "volume": "15", "first-page": "1143", "year": "1997", "journal-title": "J Clin Oncol.", "DOI": "10.1200/JCO.1997.15.3.1143", "doi-asserted-by": "crossref"}, {"key": "BIB13", "author": "Rebulla", "volume": "337", "first-page": "1870", "year": "1997", "journal-title": "N Engl J Med.", "DOI": "10.1056/NEJM199712253372602", "doi-asserted-by": "crossref"}, {"key": "BIB14", "author": "Wandt", "volume": "91", "first-page": "3601", "year": "1998", "journal-title": "Blood."}, {"key": "BIB15", "author": "Schiffer", "volume": "19", "first-page": "1519", "year": "2001", "journal-title": "J Clin Oncol.", "DOI": "10.1200/JCO.2001.19.5.1519", "doi-asserted-by": "crossref"}, {"key": "BIB16", "author": "McCullough", "volume": "37", "first-page": "3", "year": "2000", "journal-title": "Semin Hematol.", "DOI": "10.1016/S0037-1963(00)90047-7", "doi-asserted-by": "crossref"}, {"key": "BIB17", "author": "Rinder", "volume": "6", "first-page": "437", "year": "1999", "journal-title": "Curr Opin Hematol.", "DOI": "10.1097/00062752-199911000-00015", "doi-asserted-by": "crossref"}, {"key": "BIB18", "author": "Tepler", "volume": "87", "first-page": "3607", "year": "1996", "journal-title": "Blood."}, {"key": "BIB19", "author": "Isaacs", "volume": "15", "first-page": "3368", "year": "1997", "journal-title": "J Clin Oncol.", "DOI": "10.1200/JCO.1997.15.11.3368", "doi-asserted-by": "crossref"}, {"key": "BIB20", "author": "Basser", "first-page": "266", "year": "1999", "unstructured": "Clinical use of thrombopoietic growth factors. In: American Society of Clinical Oncology Educational Book. Alexandria, VA: American Society of Clinical Oncology, 1999: 266-274.", "volume-title": "American Society of Clinical Oncology Educational Book"}, {"key": "BIB21", "author": "Kaushansky", "volume": "339", "first-page": "746", "year": "1998", "journal-title": "N Engl J Med.", "DOI": "10.1056/NEJM199809103391107", "doi-asserted-by": "crossref"}, {"key": "BIB22", "author": "Elting", "volume": "13", "first-page": "587", "year": "1999", "journal-title": "Oncology."}, {"key": "BIB23", "author": "Elting", "volume": "19", "first-page": "1137", "year": "2001", "journal-title": "J Clin Oncol.", "DOI": "10.1200/JCO.2001.19.4.1137", "doi-asserted-by": "crossref"}, {"key": "BIB24", "author": "Malone", "volume": "14", "first-page": "305", "year": "1995", "journal-title": "J Clin Oncol."}, {"key": "BIB25", "author": "Calhoun", "volume": "6", "first-page": "441", "year": "2001", "journal-title": "Oncologist.", "DOI": "10.1634/theoncologist.6-5-441", "doi-asserted-by": "crossref"}, {"key": "BIB26", "author": "Zubrod", "volume": "11", "first-page": "7", "year": "1960", "journal-title": "J Chron Dis.", "DOI": "10.1016/0021-9681(60)90137-5", "doi-asserted-by": "crossref"}, {"key": "BIB27", "author": "Lill", "year": "1996", "unstructured": "et al. Epidemiology and cost analysis of platelet transfusions at a tertiary care medical center. Blood Cell and Bone Marrow Transplantation Symposium, Keystone CO, January 1996 [abstract]."}, {"key": "BIB28", "author": "Hartmann", "volume": "126", "first-page": "600", "year": "1997", "journal-title": "Ann Intern Med.", "DOI": "10.7326/0003-4819-126-8-199704150-00002", "doi-asserted-by": "crossref"}, {"key": "BIB29", "author": "Bernstein", "volume": "91", "first-page": "3509", "year": "1998", "journal-title": "Blood."}, {"key": "BIB30", "author": "Jefferies", "volume": "41", "first-page": "522", "year": "2001", "journal-title": "Transfusion.", "DOI": "10.1046/j.1537-2995.2001.41040522.x", "doi-asserted-by": "crossref"}, {"key": "BIB31", "author": "Meehan", "volume": "64", "first-page": "251", "year": "2000", "journal-title": "Am J Hemat.", "DOI": "10.1002/1096-8652(200008)64:4<251::AID-AJH3>3.0.CO;2-N", "doi-asserted-by": "crossref"}, {"key": "BIB32", "author": "McCullough", "volume": "259", "first-page": "2414", "year": "1988", "journal-title": "J Am Med Assoc.", "DOI": "10.1001/jama.1988.03720160034026", "doi-asserted-by": "crossref"}, {"key": "BIB33", "author": "Zimmerman", "volume": "37", "first-page": "1075", "year": "1997", "journal-title": "Transfusion.", "DOI": "10.1046/j.1537-2995.1997.371098016449.x", "doi-asserted-by": "crossref"}, {"key": "BIB34", "author": "Snider", "volume": "88", "first-page": "333a", "year": "1996", "journal-title": "Blood."}, {"key": "BIB35", "author": "Balducci", "volume": "33", "first-page": "665", "year": "1993", "journal-title": "Transfusion.", "DOI": "10.1046/j.1537-2995.1993.33893342749.x", "doi-asserted-by": "crossref"}, {"key": "BIB36", "author": "Ackernan", "volume": "40", "first-page": "1457", "year": "2000", "journal-title": "Transfusion.", "DOI": "10.1046/j.1537-2995.2000.40121457.x", "doi-asserted-by": "crossref"}, {"key": "BIB37", "author": "Lopez-Plaza", "volume": "39", "first-page": "925", "year": "1999", "journal-title": "Transfusion.", "DOI": "10.1046/j.1537-2995.1999.39090925.x", "doi-asserted-by": "crossref"}, {"key": "BIB38", "author": "Freedman", "volume": "29", "first-page": "201", "year": "1989", "journal-title": "Transfusion.", "DOI": "10.1046/j.1537-2995.1989.29389162723.x", "doi-asserted-by": "crossref"}, {"key": "BIB39", "author": "Webb", "volume": "34", "first-page": "71", "year": "1999", "journal-title": "Leukemia Lymphoma.", "DOI": "10.3109/10428199909083382", "doi-asserted-by": "crossref"}, {"key": "BIB40", "author": "Savarese", "volume": "15", "first-page": "2981", "year": "1997", "journal-title": "J Clin Oncol.", "DOI": "10.1200/JCO.1997.15.8.2981", "doi-asserted-by": "crossref"}, {"key": "BIB41", "author": "Elting", "volume": "94", "first-page": "3252", "year": "2002", "journal-title": "Cancer.", "DOI": "10.1002/cncr.10603", "doi-asserted-by": "crossref"}, {"key": "BIB42", "author": "Kuter", "volume": "39", "first-page": "321", "year": "1999", "journal-title": "Transfusion.", "DOI": "10.1046/j.1537-2995.1999.39399219292.x", "doi-asserted-by": "crossref"}], "container-title": ["Cancer"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.11195", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.11195", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 1]], "date-time": "2018-08-01T23:52:04Z", "timestamp": 1533167524000}, "score": 25.379864, "issued": {"date-parts": [[2003, 3, 3]]}, "references-count": 42, "journal-issue": {"published-print": {"date-parts": [[2003, 3, 15]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1002/cncr.11195", "relation": {"cites": []}, "ISSN": ["0008-543X", "1097-0142"], "issn-type": [{"value": "0008-543X", "type": "print"}, {"value": "1097-0142", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:57:51Z", "timestamp": 1576799871899}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "16_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2005, 6]]}, "DOI": "10.1200/jco.2005.23.16_suppl.8210", "type": "journal-article", "created": {"date-parts": [[2017, 2, 23]], "date-time": "2017-02-23T18:55:09Z", "timestamp": 1487876109000}, "page": "8210-8210", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Efficacy of darbepoetin alfa in chemotherapy-induced anemia in gastrointestinal cancers"], "prefix": "10.1200", "volume": "23", "author": [{"given": "D.", "family": "Blayney", "sequence": "first", "affiliation": [{"name": "Univ of Michigan Cancer Ctr, Ann Arbor, MI; MD Anderson Cancer Ctr, Houston, TX; Amgen Inc., Thousand Oaks, CA; Ctr for Oncology Research &amp; Treatment, Dallas, TX"}]}, {"given": "S.", "family": "Vadhan-Raj", "sequence": "additional", "affiliation": [{"name": "Univ of Michigan Cancer Ctr, Ann Arbor, MI; MD Anderson Cancer Ctr, Houston, TX; Amgen Inc., Thousand Oaks, CA; Ctr for Oncology Research &amp; Treatment, Dallas, TX"}]}, {"given": "D.", "family": "Tomita", "sequence": "additional", "affiliation": [{"name": "Univ of Michigan Cancer Ctr, Ann Arbor, MI; MD Anderson Cancer Ctr, Houston, TX; Amgen Inc., Thousand Oaks, CA; Ctr for Oncology Research &amp; Treatment, Dallas, TX"}]}, {"given": "G.", "family": "Rossi", "sequence": "additional", "affiliation": [{"name": "Univ of Michigan Cancer Ctr, Ann Arbor, MI; MD Anderson Cancer Ctr, Houston, TX; Amgen Inc., Thousand Oaks, CA; Ctr for Oncology Research &amp; Treatment, Dallas, TX"}]}, {"given": "B.", "family": "Mirtsching", "sequence": "additional", "affiliation": [{"name": "Univ of Michigan Cancer Ctr, Ann Arbor, MI; MD Anderson Cancer Ctr, Houston, TX; Amgen Inc., Thousand Oaks, CA; Ctr for Oncology Research &amp; Treatment, Dallas, TX"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2005.23.16_suppl.8210", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:16:44Z", "timestamp": 1574889404000}, "score": 25.316471, "issued": {"date-parts": [[2005, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2005, 6]]}, "issue": "16_suppl"}, "alternative-id": ["10.1200/jco.2005.23.16_suppl.8210"], "URL": "http://dx.doi.org/10.1200/jco.2005.23.16_suppl.8210", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T11:28:04Z", "timestamp": 1575286084355}, "reference-count": 0, "publisher": "Research Information Ltd.", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Outlook Pest Man"], "published-print": {"date-parts": [[2005, 10, 1]]}, "DOI": "10.1564/16oct11", "type": "journal-article", "created": {"date-parts": [[2008, 7, 16]], "date-time": "2008-07-16T02:56:08Z", "timestamp": 1216176968000}, "page": "225-229", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Current Status and Management Options of Exotic and Invasive Weeds of Forestry in Coastal British Columbia, Canada"], "prefix": "10.1564", "volume": "16", "author": [{"given": "Raj", "family": "Prasad", "sequence": "first", "affiliation": []}], "member": "433", "container-title": ["Outlooks on Pest Management"], "language": "en", "deposited": {"date-parts": [[2011, 6, 20]], "date-time": "2011-06-20T18:41:54Z", "timestamp": 1308595314000}, "score": 24.62997, "issued": {"date-parts": [[2005, 10, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2005, 10, 1]]}, "issue": "5"}, "alternative-id": ["1743-1026(20051001)16:5L.225;1-"], "URL": "http://dx.doi.org/10.1564/16oct11", "ISSN": ["1743-1026", "1743-1034"], "issn-type": [{"value": "1743-1026", "type": "print"}, {"value": "1743-1034", "type": "electronic"}], "subject": ["Biotechnology", "Agronomy and Crop Science", "Food Science", "Insect Science"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T21:21:08Z", "timestamp": 1576790468703}, "reference-count": 28, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "16", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2003, 8, 15]]}, "abstract": "<jats:p> Purpose: Recombinant human thrombopoietin (rhTPO) increases platelets, and the peak response of rhTPO is delayed and is, therefore, not uniformly effective when administered after chemotherapy. The purpose of this study was to identify an effective schedule of rhTPO to best attenuate early thrombocytopenia. </jats:p><jats:p> Patients and Methods: Cohorts of six patients with sarcoma (66 assessable patients) were treated sequentially with doxorubicin and ifosfamide (AI), with rhTPO by a fixed dose and varying schedules being administered before and/or after chemotherapy in cycle 2 and subsequent cycles. Cycle 1 without rhTPO served as an internal control. </jats:p><jats:p> Results: AI causes cumulative thrombocytopenia. The platelet nadir in cycle 2 was higher than in cycle 1 (mean nadir \u00b1 SEM, 119 \u00b1 12 \u00d7 10<jats:sup>3</jats:sup>/\u03bcL v 80 \u00b1 7 \u00d7 10<jats:sup>3</jats:sup>/\u03bcL, respectively; P &lt; .001) in 24 (80%) of the 30 patients (P &lt; .001) in whom rhTPO (1.2 \u03bcg/kg) was administered starting from 5 days before chemotherapy (pre/postdoses, three/one or one/one) compared with only four (17%) of 24 patients given rhTPO by other schedules (pre/postdoses, two/two, one/three, zero/four, or four/zero) and none of 15 historical control patients. The need for platelet transfusions in four cycles was significantly lower (13 [11%] of 114 cycles, P &lt; .001) in patients who received rhTPO from day \u22125 (pre/post doses, three/one or one/one) compared with patients who received rhTPO at later time points (28 [47%] of 60 cycles). Bone marrow megakaryocytes increased markedly (four-fold) before chemotherapy with predosing rhTPO and remained elevated (two-fold) after chemotherapy, which may explain the possible mechanism for response. One patient developed subclavian vein thrombosis, and no patients developed neutralizing antibodies to rhTPO. </jats:p><jats:p> Conclusion: These results demonstrate the importance of timing of rhTPO in relation to chemotherapy and indicate that, by optimizing the timing, only two doses of rhTPO (one before and one after chemotherapy) were required to significantly reduce the severity of chemotherapy-related early thrombocytopenia. </jats:p>", "DOI": "10.1200/jco.2003.08.003", "type": "journal-article", "created": {"date-parts": [[2003, 8, 14]], "date-time": "2003-08-14T22:53:56Z", "timestamp": 1060901636000}, "page": "3158-3167", "source": "Crossref", "is-referenced-by-count": 39, "title": ["Importance of Predosing of Recombinant Human Thrombopoietin to Reduce Chemotherapy-Induced Early Thrombocytopenia"], "prefix": "10.1200", "volume": "21", "author": [{"given": "Saroj", "family": "Vadhan-Raj", "sequence": "first", "affiliation": [{"name": "From the Departments of Bioimmunotherapy, Sarcoma Medical Oncology, Hematopathology, and Biostatistics, the University of Texas M.D. Anderson Cancer Center, Houston, TX; and the Department of Microbiology and Immunology, the Walther Oncology Center and the Walther Cancer Institute, Indiana University School of Medicine, Indianapolis, IN."}]}, {"given": "Shreyaskumar", "family": "Patel", "sequence": "additional", "affiliation": [{"name": "From the Departments of Bioimmunotherapy, Sarcoma Medical Oncology, Hematopathology, and Biostatistics, the University of Texas M.D. Anderson Cancer Center, Houston, TX; and the Department of Microbiology and Immunology, the Walther Oncology Center and the Walther Cancer Institute, Indiana University School of Medicine, Indianapolis, IN."}]}, {"given": "Carlos", "family": "Bueso-Ramos", "sequence": "additional", "affiliation": [{"name": "From the Departments of Bioimmunotherapy, Sarcoma Medical Oncology, Hematopathology, and Biostatistics, the University of Texas M.D. Anderson Cancer Center, Houston, TX; and the Department of Microbiology and Immunology, the Walther Oncology Center and the Walther Cancer Institute, Indiana University School of Medicine, Indianapolis, IN."}]}, {"given": "Jody", "family": "Folloder", "sequence": "additional", "affiliation": [{"name": "From the Departments of Bioimmunotherapy, Sarcoma Medical Oncology, Hematopathology, and Biostatistics, the University of Texas M.D. Anderson Cancer Center, Houston, TX; and the Department of Microbiology and Immunology, the Walther Oncology Center and the Walther Cancer Institute, Indiana University School of Medicine, Indianapolis, IN."}]}, {"given": "Nicholas", "family": "Papadopolous", "sequence": "additional", "affiliation": [{"name": "From the Departments of Bioimmunotherapy, Sarcoma Medical Oncology, Hematopathology, and Biostatistics, the University of Texas M.D. Anderson Cancer Center, Houston, TX; and the Department of Microbiology and Immunology, the Walther Oncology Center and the Walther Cancer Institute, Indiana University School of Medicine, Indianapolis, IN."}]}, {"given": "Andrew", "family": "Burgess", "sequence": "additional", "affiliation": [{"name": "From the Departments of Bioimmunotherapy, Sarcoma Medical Oncology, Hematopathology, and Biostatistics, the University of Texas M.D. Anderson Cancer Center, Houston, TX; and the Department of Microbiology and Immunology, the Walther Oncology Center and the Walther Cancer Institute, Indiana University School of Medicine, Indianapolis, IN."}]}, {"given": "Lyle D.", "family": "Broemeling", "sequence": "additional", "affiliation": [{"name": "From the Departments of Bioimmunotherapy, Sarcoma Medical Oncology, Hematopathology, and Biostatistics, the University of Texas M.D. Anderson Cancer Center, Houston, TX; and the Department of Microbiology and Immunology, the Walther Oncology Center and the Walther Cancer Institute, Indiana University School of Medicine, Indianapolis, IN."}]}, {"given": "Hal E.", "family": "Broxmeyer", "sequence": "additional", "affiliation": [{"name": "From the Departments of Bioimmunotherapy, Sarcoma Medical Oncology, Hematopathology, and Biostatistics, the University of Texas M.D. Anderson Cancer Center, Houston, TX; and the Department of Microbiology and Immunology, the Walther Oncology Center and the Walther Cancer Institute, Indiana University School of Medicine, Indianapolis, IN."}]}, {"given": "Robert S.", "family": "Benjamin", "sequence": "additional", "affiliation": [{"name": "From the Departments of Bioimmunotherapy, Sarcoma Medical Oncology, Hematopathology, and Biostatistics, the University of Texas M.D. Anderson Cancer Center, Houston, TX; and the Department of Microbiology and Immunology, the Walther Oncology Center and the Walther Cancer Institute, Indiana University School of Medicine, Indianapolis, IN."}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.08.003", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T20:46:40Z", "timestamp": 1574887600000}, "score": 24.595871, "issued": {"date-parts": [[2003, 8, 15]]}, "references-count": 28, "journal-issue": {"published-print": {"date-parts": [[2003, 8, 15]]}, "issue": "16"}, "alternative-id": ["10.1200/JCO.2003.08.003"], "URL": "http://dx.doi.org/10.1200/jco.2003.08.003", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T04:55:12Z", "timestamp": 1574484912112}, "reference-count": 0, "publisher": "American Society for Microbiology", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Antimicrobial Agents and Chemotherapy"], "published-print": {"date-parts": [[1983, 3, 1]]}, "DOI": "10.1128/aac.23.3.422", "type": "journal-article", "created": {"date-parts": [[2012, 6, 28]], "date-time": "2012-06-28T00:03:40Z", "timestamp": 1340841820000}, "page": "422-428", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Effect of physiological manipulations on the chemotherapy of experimentally induced renal infection."], "prefix": "10.1128", "volume": "23", "author": [{"given": "T", "family": "Miller", "sequence": "first", "affiliation": []}, {"given": "S", "family": "Phillips", "sequence": "additional", "affiliation": []}], "member": "235", "container-title": ["Antimicrobial Agents and Chemotherapy"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1128/AAC.23.3.422", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T16:29:45Z", "timestamp": 1482510585000}, "score": 24.458267, "issued": {"date-parts": [[1983, 3, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1983, 3, 1]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1128/aac.23.3.422", "ISSN": ["0066-4804", "1098-6596"], "issn-type": [{"value": "0066-4804", "type": "print"}, {"value": "1098-6596", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T19:33:44Z", "timestamp": 1575228824457}, "reference-count": 0, "publisher": "Frontiers Media SA", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Front. Neurol."], "DOI": "10.3389/fneur.2013.00059", "type": "journal-article", "created": {"date-parts": [[2013, 5, 30]], "date-time": "2013-05-30T07:35:05Z", "timestamp": 1369899305000}, "source": "Crossref", "is-referenced-by-count": 47, "title": ["Mathematical Models of Blast-Induced TBI: Current Status, Challenges, and Prospects"], "prefix": "10.3389", "volume": "4", "author": [{"given": "Raj K.", "family": "Gupta", "sequence": "first", "affiliation": []}, {"given": "Andrzej", "family": "Przekwas", "sequence": "additional", "affiliation": []}], "member": "1965", "published-online": {"date-parts": [[2013]]}, "container-title": ["Frontiers in Neurology"], "deposited": {"date-parts": [[2015, 2, 18]], "date-time": "2015-02-18T19:31:05Z", "timestamp": 1424287865000}, "score": 24.427898, "issued": {"date-parts": [[2013]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3389/fneur.2013.00059", "ISSN": ["1664-2295"], "issn-type": [{"value": "1664-2295", "type": "electronic"}], "subject": ["Neurology", "Clinical Neurology"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T18:48:05Z", "timestamp": 1574102885993}, "reference-count": 17, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1995, 3, 1]], "date-time": "1995-03-01T00:00:00Z", "timestamp": 794016000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The American Journal of Medicine"], "published-print": {"date-parts": [[1995, 3]]}, "DOI": "10.1016/s0002-9343(99)80366-0", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T20:39:08Z", "timestamp": 1027629548000}, "page": "221-223", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Is it time to redefine the management of febrile neutropenia in cancer patients?"], "prefix": "10.1016", "volume": "98", "author": [{"given": "Elias J.", "family": "Anaissie", "sequence": "first", "affiliation": []}, {"given": "Saroj", "family": "Vadhan-Raj", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["The American Journal of Medicine"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0002934399803660?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0002934399803660?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 21]], "date-time": "2019-04-21T06:56:04Z", "timestamp": 1555829764000}, "score": 23.865288, "issued": {"date-parts": [[1995, 3]]}, "references-count": 17, "journal-issue": {"published-print": {"date-parts": [[1995, 3]]}, "issue": "3"}, "alternative-id": ["S0002934399803660"], "URL": "http://dx.doi.org/10.1016/s0002-9343(99)80366-0", "ISSN": ["0002-9343"], "issn-type": [{"value": "0002-9343", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T02:13:12Z", "timestamp": 1575425592982}, "reference-count": 21, "publisher": "Springer Science and Business Media LLC", "issue": "5", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2014, 1, 12]], "date-time": "2014-01-12T00:00:00Z", "timestamp": 1389484800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Support Care Cancer"], "published-print": {"date-parts": [[2014, 5]]}, "DOI": "10.1007/s00520-013-2074-2", "type": "journal-article", "created": {"date-parts": [[2014, 1, 11]], "date-time": "2014-01-11T07:19:48Z", "timestamp": 1389424788000}, "page": "1217-1222", "source": "Crossref", "is-referenced-by-count": 31, "title": ["Romiplostim for management of chemotherapy-induced thrombocytopenia"], "prefix": "10.1007", "volume": "22", "author": [{"given": "R.", "family": "Parameswaran", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Lunning", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Mantha", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Devlin", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Hamilton", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Schwartz", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Soff", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2014, 1, 12]]}, "reference": [{"key": "2074_CR1", "doi-asserted-by": "crossref", "first-page": "1137", "DOI": "10.1200/JCO.2001.19.4.1137", "volume": "19", "author": "LS Elting", "year": "2001", "unstructured": "Elting LS, Rubenstein EB, Martin CG et al (2001) Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia. J Clin Oncol 19:1137\u20131146", "journal-title": "J Clin Oncol"}, {"key": "2074_CR2", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1053/j.seminhematol.2010.02.005", "volume": "47", "author": "DJ Kuter", "year": "2010", "unstructured": "Kuter DJ (2010) Biology and chemistry of thrombopoietic agents. Semin Hematol 47:243\u2013248", "journal-title": "Semin Hematol"}, {"key": "2074_CR3", "doi-asserted-by": "crossref", "first-page": "3457", "DOI": "10.1182/blood.V100.10.3457", "volume": "100", "author": "DJ Kuter", "year": "2002", "unstructured": "Kuter DJ, Begley CG (2002) Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Blood 100:3457\u20133469", "journal-title": "Blood"}, {"key": "2074_CR4", "doi-asserted-by": "crossref", "first-page": "3241", "DOI": "10.1182/blood.V98.12.3241", "volume": "98", "author": "J Li", "year": "2001", "unstructured": "Li J, Yang C, Xia Y et al (2001) Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 98:3241\u20133248", "journal-title": "Blood"}, {"key": "2074_CR5", "doi-asserted-by": "crossref", "first-page": "28", "DOI": "10.1016/S0037-1963(00)90050-7", "volume": "37", "author": "S Vadhan-Raj", "year": "2000", "unstructured": "Vadhan-Raj S (2000) Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia. Semin Hematol 37:28\u201334", "journal-title": "Semin Hematol"}, {"key": "2074_CR6", "doi-asserted-by": "crossref", "first-page": "52", "DOI": "10.1016/j.cyto.2003.05.001", "volume": "25", "author": "VC Broudy", "year": "2004", "unstructured": "Broudy VC, Lin NL (2004) AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl. Cytokine 25:52\u201360", "journal-title": "Cytokine"}, {"key": "2074_CR7", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1053/j.seminhematol.2010.02.005", "volume": "47", "author": "DJ Kuter", "year": "2010", "unstructured": "Kuter DJ (2010) Biology and chemistry of thrombopoietic agents. Semin Hematol 47:243\u2013248", "journal-title": "Semin Hematol"}, {"key": "2074_CR8", "doi-asserted-by": "crossref", "first-page": "384", "DOI": "10.1182/asheducation-2011.1.384", "volume": "2011", "author": "HA Liebman", "year": "2011", "unstructured": "Liebman HA, Pullarkat V (2011) Diagnosis and management of immune thrombocytopenia in the era of thrombopoietin mimetics. Hematol Am Soc Hematol Educ Program 2011:384\u2013390", "journal-title": "Hematol Am Soc Hematol Educ Program"}, {"key": "2074_CR9", "doi-asserted-by": "crossref", "first-page": "563", "DOI": "10.1016/S1359-6349(09)71900-7", "volume": "7", "author": "M Fanale", "year": "2009", "unstructured": "Fanale M, Stiff P, Noonan K et al (2009) Safety of romiplostim for treatment of severe chemotherapy induced thrombocytopenia (CIT) in patients with lymphoma receiving multi-cycle chemotherapy: results from an open-label dose- and schedule-finding study (abstract). EJC Suppl 7:563\u2013563", "journal-title": "EJC Suppl"}, {"key": "2074_CR10", "doi-asserted-by": "crossref", "first-page": "574", "DOI": "10.1016/S1359-6349(09)71939-1", "volume": "7", "author": "R Natale", "year": "2009", "unstructured": "Natale R, Charu V, Schutte W et al (2009) Safety of romiplostim for treatment of chemotherapy-induced thrombocytopenia (CIT) in patients with advanced non-small cell lung cancer (NSCLC) (abstract). EJC Suppl 7:574\u2013574", "journal-title": "EJC Suppl"}, {"key": "2074_CR11", "first-page": "656", "volume": "116", "author": "S Vadhan-Raj", "year": "2010", "unstructured": "Vadhan-Raj S, Hagemeister F, Fayad LE et al (2010) Randomized, double-blind, placebo-controlled, dose and schedule-finding study of AMG 531 In chemotherapy-induced thrombocytopenia (CIT): results of a phase I/II study (abstract). Blood 116:656\u2013657", "journal-title": "Blood"}, {"key": "2074_CR12", "unstructured": "Winer ES, Safran H, Karaszewska B, et al.: Safety and efficacy of eltrombopag (epag) versus placebo (pbo) for the treatment (tx) of chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors receiving gemcitabine (gem)-based chemotherapy (ctx): A phase I study. J Clin Oncol (suppl) 30, 2012"}, {"key": "2074_CR13", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1111/j.1365-2141.2012.09194.x", "volume": "158", "author": "K Gardner", "year": "2012", "unstructured": "Gardner K, Mathe S, Sahu S (2012) Leukaemic transformation with romiplostim. Br J Haematol 158:153", "journal-title": "Br J Haematol"}, {"key": "2074_CR14", "doi-asserted-by": "crossref", "first-page": "914", "DOI": "10.1001/jama.299.8.914", "volume": "299", "author": "CL Bennett", "year": "2008", "unstructured": "Bennett CL, Silver SM, Djulbegovic B et al (2008) Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 299:914\u2013924", "journal-title": "JAMA"}, {"key": "2074_CR15", "doi-asserted-by": "crossref", "first-page": "628", "DOI": "10.6004/jnccn.2012.0064", "volume": "10", "author": "GM Rodgers 3rd", "year": "2012", "unstructured": "Rodgers GM 3rd, Becker PS, Blinder M et al (2012) Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw 10:628\u2013653", "journal-title": "J Natl Compr Canc Netw"}, {"key": "2074_CR16", "unstructured": "Tonia T, Mettler A, Robert N et al (2012) Erythropoietin or darbepoetin for patients with cancer. Cochrane database syst rev 12:CD003407", "DOI": "10.1002/14651858.CD003407.pub5", "doi-asserted-by": "crossref"}, {"key": "2074_CR17", "doi-asserted-by": "crossref", "first-page": "1611", "DOI": "10.1111/j.1538-7836.2005.01415.x", "volume": "3", "author": "JA Heit", "year": "2005", "unstructured": "Heit JA (2005) Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost : JTH 3:1611\u20131617", "journal-title": "J Thromb Haemost : JTH"}, {"issue": "Suppl 3", "key": "2074_CR18", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.1093/annonc/11.suppl_3.273", "volume": "11", "author": "HF Hillen", "year": "2000", "unstructured": "Hillen HF (2000) Thrombosis in cancer patients. Ann Oncol : Off J Eur Soc Med Oncol/ESMO 11(Suppl 3):273\u2013276", "journal-title": "Ann Oncol : Off J Eur Soc Med Oncol/ESMO"}, {"key": "2074_CR19", "doi-asserted-by": "crossref", "first-page": "4027", "DOI": "10.1182/blood-2005-04-1508", "volume": "106", "author": "P Prandoni", "year": "2005", "unstructured": "Prandoni P (2005) How I treat venous thromboembolism in patients with cancer. Blood 106:4027\u20134033", "journal-title": "Blood"}, {"key": "2074_CR20", "doi-asserted-by": "crossref", "first-page": "401", "DOI": "10.1016/S1470-2045(05)70207-2", "volume": "6", "author": "P Prandoni", "year": "2005", "unstructured": "Prandoni P, Falanga A, Piccioli A (2005) Cancer and venous thromboembolism. Lancet Oncol 6:401\u2013410", "journal-title": "Lancet Oncol"}, {"key": "2074_CR21", "doi-asserted-by": "crossref", "first-page": "3748", "DOI": "10.1182/blood-2009-05-224766", "volume": "114", "author": "DJ Kuter", "year": "2009", "unstructured": "Kuter DJ, Mufti GJ, Bain BJ et al (2009) Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim. Blood 114:3748\u20133756", "journal-title": "Blood"}], "container-title": ["Supportive Care in Cancer"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00520-013-2074-2.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00520-013-2074-2/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00520-013-2074-2", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 6]], "date-time": "2019-08-06T10:54:14Z", "timestamp": 1565088854000}, "score": 23.830582, "issued": {"date-parts": [[2014, 1, 12]]}, "references-count": 21, "journal-issue": {"published-print": {"date-parts": [[2014, 5]]}, "issue": "5"}, "alternative-id": ["2074"], "URL": "http://dx.doi.org/10.1007/s00520-013-2074-2", "relation": {"cites": []}, "ISSN": ["0941-4355", "1433-7339"], "issn-type": [{"value": "0941-4355", "type": "print"}, {"value": "1433-7339", "type": "electronic"}], "subject": ["Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T08:05:20Z", "timestamp": 1574409920630}, "publisher-location": "Boston, MA", "reference-count": 21, "publisher": "Springer US", "isbn-type": [{"value": "9781461338390", "type": "print"}, {"value": "9781461338376", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1984]]}, "DOI": "10.1007/978-1-4613-3837-6_10", "type": "book-chapter", "created": {"date-parts": [[2011, 10, 17]], "date-time": "2011-10-17T11:08:39Z", "timestamp": 1318849719000}, "page": "77-82", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Current Clinical Progress with New Agents: Alkylating Agents"], "prefix": "10.1007", "author": [{"given": "S.", "family": "Eckhardt", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "10_CR1", "first-page": "1729", "volume": "20", "author": "V Meyer", "year": "1887", "unstructured": "Meyer Vr. Medizinisch-chemische Notizen. II. Physiologische Wirkung der gechlorten Schwefelaethyle. Brichte der Deutsch. Chem. Ges. /20/: 1729\u20131731, 1887.", "journal-title": "Chem. Ges"}, {"key": "10_CR2", "doi-asserted-by": "publisher", "first-page": "190", "DOI": "10.1097/00000658-193101000-00026", "volume": "93", "author": "FE Adair", "year": "1931", "unstructured": "Adair F. E., Bagg H. J.: Experimental and clinical studies on the treatment of cancer by dichloroethylsulfide. Ann. Surg. /93/: 190\u2013199, 1931.", "journal-title": "Ann. Surg"}, {"key": "10_CR3", "doi-asserted-by": "publisher", "first-page": "409", "DOI": "10.1126/science.103.2675.409", "volume": "103", "author": "A Gilman", "year": "1946", "unstructured": "Gilman A., Philips F. S.: The biological actions and therapeutic applications of the \u00df-chloroethylamines and sulfides. Science /103/: 409\u2013415, 1946.", "journal-title": "Science"}, {"key": "10_CR4", "author": "WCJ Ross", "first-page": "33", "year": "1975", "unstructured": "Ross W. C. J.: Rational design of alkylating agents. In: Sartorelli A.L., Johns D.G. /ed/ Antineoplastic and Immunosuppressive Agents I. Springer Verlag, Berlin, Heidelberg, New York. 1975, pp. 33\u201351.", "volume-title": "Antineoplastic and Immunosuppressive Agents I"}, {"key": "10_CR5", "author": "N Brock", "first-page": "1", "year": "1980", "unstructured": "Brock N.: Konzeption und Wirkungsmechanismus von Uromitexan /Mesna/. In:. Burkert H., Nagel G. A.: Neue Erfahrungen mit Oxazaphosphorinen unter besonderer Ber\u00fccksichtigung des Uroprotektors Uromitexan. Karger Verlag. Basel, M\u00fcnchen, Paris, London, New York, Sidney. 1980. pp. 1\u201311.", "volume-title": "Konzeption und Wirkungsmechanismus von Uromitexan /Mesna/. In:. Burkert H., Nagel G. A.: Neue Erfahrungen mit Oxazaphosphorinen unter besonderer Ber\u00fccksichtigung des Uroprotektors Uromitexan. Karger Verlag. Basel, M\u00fcnchen, Paris"}, {"key": "10_CR6", "author": "W Welleus", "first-page": "84", "year": "1980", "unstructured": "Welleus W., Mussgung G., Habets L., Schafer E., Westerhausen M.: Die Kombination Ifosfamid/VP-16213 bei der Therapie des kleinzelligen Bronchialkarzinoms und anderer Malignome. In: Burkert H., Nagel G. A.: Neue Erfahrungen mit Oxazaphosphorinen unter besonderer Ber\u00fccksichtigung des Uroprotektors Uromitexan. Karger Verlag. Basel, M\u00fcnchen, Paris, London, New York, Sidney. 1980. pp. 84\u201390.", "volume-title": "Neue Erfahrungen mit Oxazaphosphorinen unter besonderer Ber\u00fccksichtigung des Uroprotektors Uromitexan. Karger Verlag. Basel, M\u00fcnchen, Paris", "DOI": "10.1159/000393482", "doi-asserted-by": "crossref"}, {"key": "10_CR7", "author": "I K\u00f6nyves", "first-page": "303", "year": "1977", "unstructured": "K\u00f6nyves I., Fex H., Hogberg B., Jensen C., Stamwik A.: Steroid-N-nitroso-omega-haloalkyl carbamates. In: Davis W., Harrap K. R.: Characterization and Treatment of Human Tumours. Proc. VII.Internat.Symp. on the Biological Characterization of Human Tumors, Budapest. Excerpta Med. Amsterdam 1977. pp. 303\u2013307.", "volume-title": "Characterization and Treatment of Human Tumours. Proc. VII.Internat.Symp. on the Biological Characterization of Human Tumors, Budapest"}, {"key": "10_CR8", "author": "I K\u00f6nyves", "first-page": "303", "year": "1977", "unstructured": "K\u00f6nyves I., W\u00e4hlby S.: Review on clinical experiences with prednimustine. In: Davis W., Harrap K. R.: Characterization and Treatment of human tumours. Proc. VII. Internat.Symp. on the Biological Characterization of Human Tumours, Budapest. Excerpta Med. Amsterdam 1977. pp. 303\u2013307.", "volume-title": "Characterization and Treatment of human tumours. Proc. VII. Internat.Symp. on the Biological Characterization of Human Tumours, Budapest"}, {"key": "10_CR9", "doi-asserted-by": "publisher", "first-page": "997", "DOI": "10.1016/S0300-9084(78)80586-0", "volume": "60", "author": "JA Hickman", "year": "1978", "unstructured": "Hickman J. A.: Investigation of the mechanism of action of antitumor dimethyltriazenes. Biochimie /60/: 997\u20131006, 1978.", "journal-title": "Biochimie"}, {"key": "10_CR10", "first-page": "204", "volume": "20", "author": "AE Stanbus", "year": "1979", "unstructured": "Stanbus A. E., Ken T. A., Balcerzak S. P., Randall G., Neidhart J. A.: Pharmacokinetics of pyrazolo-imidazole /IMPY/ in humans. Proc.Amer.Ass.Cancer Res. /20/: 204, 1979.", "journal-title": "Proc. Amer. Ass. Cancer Res"}, {"key": "10_CR11", "author": "L Instit\u00f3ris", "first-page": "250", "year": "1963", "unstructured": "Instit\u00f3ris L., Horv\u00e1th I. P., Cs\u00e1nyi E.: Activit\u00e9 cytostatique de certains d\u00e9riv\u00e9s halog\u00e9n\u00e9s de polyalcools. In: Proc. of the II. Symp. Internat. Chimiotherapy, Naples 1961. Karger, New York 1963. pp. 250\u2013253.", "volume-title": "Proc. of the II. Symp. Internat. Chimiotherapy, Naples"}, {"key": "10_CR12", "first-page": "57", "volume": "33", "author": "S Eckhardt", "year": "1973", "unstructured": "Eckhardt S., Sellei C., Horv\u00e1th I. P., Instit\u00f3ris L.: Effect of 1, 6-dibromo-l, 6-dideoxy-D-mannitol on chronic granulocytic leukemia. Cancer Chemother. Rep. /33/: 57\u201361, 1973.", "journal-title": "Cancer Chemother. Rep"}, {"key": "10_CR13", "doi-asserted-by": "publisher", "first-page": "583", "DOI": "10.1016/0014-2964(73)90149-7", "volume": "9", "author": "Dibromomannitol Cooperative Study Group Report", "year": "1973", "unstructured": "Dibromomannitol Cooperative Study Group Report. Survival of CML patients treated by Dibromomannitol. Europ. J. Cancer /9/: 583\u2013589, 1973.", "journal-title": "Europ. J. Cancer"}, {"key": "10_CR14", "doi-asserted-by": "publisher", "first-page": "402", "DOI": "10.1038/213402a0", "volume": "213", "author": "B Kellner", "year": "1967", "unstructured": "Kellner B., N\u00e9meth L., Horv\u00e1th I.P., Instit\u00f3ris L.: 1,6\u2013dibromo-1,6-dideoxydulcitol: A new antitumoural agent. Nature /213/: 402\u2013406, 1967.", "journal-title": "Nature"}, {"key": "10_CR15", "author": "S Eckhardt", "first-page": "181", "year": "1983", "unstructured": "Eckhardt S.: Current status of anticancer drug development in the CMEA countries. In: Hilgard P., Hellmann K.: Anticancer Drug Development. Prous J.R. publishers, Barcelona, 1983. pp. 181\u2013194.", "volume-title": "Anticancer Drug Development. Prous J.R"}, {"key": "10_CR16", "doi-asserted-by": "publisher", "first-page": "442", "DOI": "10.1002/1097-0142(19810201)47:3<442::AID-CNCR2820470304>3.0.CO;2-1", "volume": "47", "author": "DF Chiuten", "year": "1981", "unstructured": "Chiuten D. F., Rozencweig M., von Hoff D. D., Muggia F. M.: Clinical trials with the hexitol derivatives in the US. Cancer /47/: 442\u2013451, 1981.", "journal-title": "Cancer"}, {"key": "10_CR17", "author": "S Eckhardt", "year": "1982", "unstructured": "Eckhardt S.: Dibromodulcitol. Medicina Publisher, Budapest 1982.", "volume-title": "Dibromodulcitol"}, {"key": "10_CR18", "first-page": "467", "volume": "4", "author": "LA Elson", "year": "1968", "unstructured": "Elson L. A., Jarman M., Ross W. C. J.: Toxicity, haematological effects and antitumour activity of epoxides derived from disubstituted hexitols. Mode of action of mannitol myleran and dibromomannitol. Europ. J. Cane. /4/: 167\u2013171, 1968.", "journal-title": "Europ. J. Canc"}, {"key": "10_CR19", "author": "JG Kuhn", "first-page": "131", "year": "1981", "unstructured": "Kuhn J. G., von Hoff D. D., Myers J. W.: New anticancer drugs. In: Pinedo H. M.: Cancer Chemotherapy 1981. Excerpta Medica, Amsterdam-Oxford. 1981. pp. 131\u2013165.", "volume-title": "Cancer Chemotherapy"}, {"key": "10_CR20", "doi-asserted-by": "publisher", "first-page": "313", "DOI": "10.1021/jm00224a022", "volume": "19", "author": "AH Kahn", "year": "1976", "unstructured": "Kahn A. H., Driscoll J. S.: Potential CNS antitumour agents. VI. Aziridinylbenzoquinones. J.med. Chem. /19/: 313\u2013319, 1976.", "journal-title": "J. med. Chem"}, {"key": "10_CR21", "author": "DD Hoff von", "first-page": "126", "year": "1980", "unstructured": "von Hoff D. D., Kuhn J., Harris G. J.: New anticancer drugs. In: Pinedo H. M.: Cancer Chemotherapy 1980. Excerpta Medica, Amsterdam-Oxford. 1980. pp. 126\u2013127.", "volume-title": "Cancer Chemotherapy"}], "container-title": ["Cancer Chemotherapy and Selective Drug Development"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-4613-3837-6_10", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 12]], "date-time": "2019-04-12T20:44:58Z", "timestamp": 1555101898000}, "score": 23.803186, "issued": {"date-parts": [[1984]]}, "ISBN": ["9781461338390", "9781461338376"], "references-count": 21, "URL": "http://dx.doi.org/10.1007/978-1-4613-3837-6_10", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:51:41Z", "timestamp": 1576799501751}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[1994, 4]]}, "abstract": "<jats:sec><jats:title>PURPOSE</jats:title><jats:p> The purpose of this study was to evaluate the clinical safety and ability of interleukin-1 alpha (IL-1 alpha) to ameliorate carboplatin-induced thrombocytopenia and thus allow patients with ovarian cancer to receive multiple cycles of chemotherapy at full doses. </jats:p></jats:sec><jats:sec><jats:title>PATIENTS AND METHODS</jats:title><jats:p> IL-1 alpha was administered by continuous intravenous infusion daily at doses of 0.1 to 10 micrograms/m2/24 hours over 4 days (96 hours) before the first cycle and/or following the second cycle of carboplatin in 21 patients with recurrent ovarian cancer who had platinum-responsive disease. In cycle no. 1, patients received carboplatin (400 mg/m2) alone, while in cycle no. 2 carboplatin was followed by IL-1 alpha. </jats:p></jats:sec><jats:sec><jats:title>RESULTS</jats:title><jats:p> Treatment with IL-1 alpha before carboplatin was associated with moderate leukocytosis (baseline mean, 6.15 x 10(3)/microL; maximum mean, 17.9 x 10(3)/microL; P &lt; .001) and significant increases in platelet counts (baseline mean, 241 x 10(3)/microL; maximal mean, 392 x 10(3)/microL; P &lt; .001). IL-1 alpha following carboplatin significantly reduced the duration of thrombocytopenia (days platelet count &lt; 50,000, 5.1 to 2.9 days; P = .003) and increased the area under the curve (AUC) of platelets as a function of time (P &lt; .001). The mean nadir platelet counts were 54,000/microL and 67,000/microL (P = .08) in cycles no. 1 and 2, respectively. In fact, seven of 12 patients given 3 micrograms/m2/d of IL-1 alpha had less thrombocytopenia in cycle no. 2 than in cycle no. 1. Treatment with IL-1 alpha was associated with the tolerance of multiple cycles of carboplatin at the same dose in several patients. The maximum-tolerated dose (MTD) was 3 micrograms/m2/d; fever, chills, hypotension, and fluid retention were dose-limiting toxic effects. </jats:p></jats:sec><jats:sec><jats:title>CONCLUSION</jats:title><jats:p> These findings demonstrate that IL-1 alpha can enhance recovery of platelets following carboplatin therapy and suggest a potential therapeutic role for IL-1 alpha in attenuating thrombocytopenia associated with chemotherapy. </jats:p></jats:sec>", "DOI": "10.1200/jco.1994.12.4.707", "type": "journal-article", "created": {"date-parts": [[2017, 2, 23]], "date-time": "2017-02-23T13:01:34Z", "timestamp": 1487854894000}, "page": "707-714", "source": "Crossref", "is-referenced-by-count": 34, "title": ["Effects of interleukin-1 alpha on carboplatin-induced thrombocytopenia in patients with recurrent ovarian cancer."], "prefix": "10.1200", "volume": "12", "author": [{"given": "S", "family": "Vadhan-Raj", "sequence": "first", "affiliation": []}, {"given": "A P", "family": "Kudelka", "sequence": "additional", "affiliation": []}, {"given": "L", "family": "Garrison", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Gano", "sequence": "additional", "affiliation": []}, {"given": "C L", "family": "Edwards", "sequence": "additional", "affiliation": []}, {"given": "R S", "family": "Freedman", "sequence": "additional", "affiliation": []}, {"given": "J J", "family": "Kavanagh", "sequence": "additional", "affiliation": []}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/JCO.1994.12.4.707", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T20:13:27Z", "timestamp": 1574885607000}, "score": 23.519573, "issued": {"date-parts": [[1994, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1994, 4]]}, "issue": "4"}, "alternative-id": ["10.1200/JCO.1994.12.4.707"], "URL": "http://dx.doi.org/10.1200/jco.1994.12.4.707", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T16:47:36Z", "timestamp": 1574441256466}, "reference-count": 119, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Current Opinion in Hematology"], "published-print": {"date-parts": [[2010, 9]]}, "DOI": "10.1097/moh.0b013e32833c07a7", "type": "journal-article", "created": {"date-parts": [[2010, 7, 1]], "date-time": "2010-07-01T07:35:53Z", "timestamp": 1277969753000}, "page": "424-431", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Treatment options in heparin-induced thrombocytopenia"], "prefix": "10.1097", "volume": "17", "author": [{"given": "Karen M", "family": "Hook", "sequence": "first", "affiliation": []}, {"given": "Charles S", "family": "Abrams", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Current Opinion in Hematology"], "language": "en", "deposited": {"date-parts": [[2019, 3, 1]], "date-time": "2019-03-01T17:56:54Z", "timestamp": 1551463014000}, "score": 23.456026, "subtitle": [""], "issued": {"date-parts": [[2010, 9]]}, "references-count": 119, "journal-issue": {"issue": "5"}, "URL": "http://dx.doi.org/10.1097/moh.0b013e32833c07a7", "ISSN": ["1065-6251"], "issn-type": [{"value": "1065-6251", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T05:28:39Z", "timestamp": 1575178119725}, "reference-count": 0, "publisher": "Bentham Science Publishers Ltd.", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CMCCHA"], "published-print": {"date-parts": [[2005, 10, 1]]}, "DOI": "10.2174/156801605774322364", "type": "journal-article", "created": {"date-parts": [[2005, 9, 28]], "date-time": "2005-09-28T20:49:59Z", "timestamp": 1127940599000}, "page": "365-376", "source": "Crossref", "is-referenced-by-count": 15, "title": ["Thrombocytopenia in HIV Disease: Clinical Relevance, Physiopathology and Management"], "prefix": "10.2174", "volume": "3", "author": [{"given": "M.", "family": "Miguez-Burbano", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Jackson Jr.", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Hadrigan", "sequence": "additional", "affiliation": []}], "member": "965", "container-title": ["Current Medicinal Chemistry-Cardiovascular & Hematological Agents"], "language": "en", "link": [{"URL": "http://eurekaselect.com/article/download/90519", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2015, 11, 23]], "date-time": "2015-11-23T10:01:01Z", "timestamp": 1448272861000}, "score": 23.414923, "issued": {"date-parts": [[2005, 10, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2005, 10, 1]]}, "issue": "4"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/156801605774322364", "ISSN": ["1568-0169"], "issn-type": [{"value": "1568-0169", "type": "print"}], "subject": ["Pharmacology", "Hematology", "Cardiology and Cardiovascular Medicine"]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}